OBJECTIVE: The aim of the study was to evaluate systematic thyroid ultrasonography (US) relevance in newly diagnosed @entity2743 among @entity1 presenting without palpable @entity9384 . SUBJECTS AND METHODS: We consecutively recruited 208 cases of @entity2743 without palpable @entity9384 . All @entity1 were screened for thyroid antibodies and underwent a thyroid US. Ultrasonically guided biopsy was proposed for the assessment of all @entity9384 upper or equal to 10mm in diameter. RESULTS: Two third of @entity1 had an @entity1374 requiring an US. One third of @entity1 had a normal thyroid at palpation and US was consequently unwarranted. Among all @entity1 , US detected non-palpable @entity9384 in 26% of cases. We found no smears suspected to be cancerous. CONCLUSIONS: In newly diagnosed @entity2743 , the US relevance is only questionable in @entity1 without @entity1374 . Ultrasonography detected non-palpable @entity9384 and none was suspected to be cancerous. These data suggest that US is not useful in @entity1 without @entity1374 . Nevertheless, the recent Thyroid Imaging-Reporting And Data System classification (TI-RADS) might change our conclusions. The TI-RADS classification indeed improves the selection of @entity9384 lower than 10mm in diameter requiring a biopsy. Nodules lower than 10mm in diameter were not biopsied in the present study. The other US data presented herein (echogenicity, vascularisation) provide no further relevance for systematic US in newly diagnosed @entity1 .

Screening for thyroid cancer according to French recommendations with thyroid ultrasound in newly diagnosed @entity2743 without palpable XXXX is not useful.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1374 :: ('MESH:D013959', 'Disease') :: ['abnormal thyroid at palpation'] @entity9384 :: ('MESH:D016606', 'Disease') :: ['nodule', 'nodules'] @entity2743 :: ('MESH:D006111', 'Disease') :: ["Graves' disease"]
@entity9384 :: (MESH:D016606,Disease) :: ['nodule']
